Product NDC: | 0009-0775 |
Proprietary Name: | Cleocin Phosphate |
Non Proprietary Name: | CLINDAMYCIN PHOSPHATE |
Active Ingredient(s): | 150 mg/mL & nbsp; CLINDAMYCIN PHOSPHATE |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0009-0775 |
Labeler Name: | Pharmacia and Upjohn Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050441 |
Marketing Category: | NDA |
Start Marketing Date: | 19721002 |
Package NDC: | 0009-0775-26 |
Package Description: | 25 VIAL in 1 CARTON (0009-0775-26) > 4 mL in 1 VIAL (0009-0775-20) |
NDC Code | 0009-0775-26 |
Proprietary Name | Cleocin Phosphate |
Package Description | 25 VIAL in 1 CARTON (0009-0775-26) > 4 mL in 1 VIAL (0009-0775-20) |
Product NDC | 0009-0775 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CLINDAMYCIN PHOSPHATE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19721002 |
Marketing Category Name | NDA |
Labeler Name | Pharmacia and Upjohn Company |
Substance Name | CLINDAMYCIN PHOSPHATE |
Strength Number | 150 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |